Genome-wide CRISPR screen identifies synthetic lethality between DOCK1 inhibition and metformin in liver cancer
{{custom_author.name}}, {{article.zuoZheEn}}
Genome-wide CRISPR screen identifies synthetic lethality between DOCK1 inhibition and metformin in liver cancer
[{{custom_ref.label}}] |
{{custom_citation.content}}
|
/
〈 | 〉 |